IN the four decades since the first cases of what would come to be known as AIDS were documented, scientists have made huge strides in HIV treatment, transforming what was once a death sentence to a manageable condition.
What we still don't have is a vaccine that would train human immune systems to ward off the infection before it ever takes root.
Here's the state of play on some of these efforts, which experts see as the "holy grail" in the fight to eliminate a virus that 38 million people live with globally.
- Why do we need a vaccine? -
More people than ever now have access to medications called antiretroviral therapy or ART, which when taken as prescribed, keeps down the amount of virus in their body.
This keeps them healthy and unable to transmit HIV to their partners.
Beyond ART, people at high risk for infection can now get pre-exposure prophylaxis, or PrEP, a pill taken every day that reduces the risk of infection by 99 percent.
"But access to medication is not organized in every part of the world," Hanneke Schuitemaker, global head of viral vaccine discovery at Johnson & Johnson's Janssen Vaccines, told AFP.
Even within wealthy countries, wide socio-economic and racial disparities exist in accessing these medicines, and vaccines have historically been the most effective tools to eradicate infectious diseases.
J&J is currently carrying out two human efficacy trials for its HIV vaccine candidate, and initial results from one of them may come as early as "the end of this year," Schuitemaker said.
- Why is it so challenging? -
Vaccines against Covid-19 were developed in record time and have shown remarkable levels of safety and efficacy, helping drive down caseloads in the countries fortunate enough to have wide access.
Many of these shots were developed using technologies that were previously being tried out on HIV so why haven't we had breakthroughs yet?
"The human immune system doesn't self cure HIV, whereas what was very clear was the human immune system was quite capable of self curing Covid-19," Larry Corey, principal investigator of HVTN, a global organization funding HIV vaccine development, told AFP.
Covid vaccines work by eliciting antibodies that bind to the virus' spike protein and stop it from infecting human cells.
HIV also has spike-shaped proteins on its surface, which are the target of HIV vaccine development.
But while Covid has tens of well known variants circulating worldwide, HIV has hundreds or thousands of variants inside each infected person, William Schief, an immunologist leading development of an mRNA HIV vaccine at Scripps Research Institute told AFP.
Because it's a "retrovirus" it quickly incorporates itself into its host's DNA. An effective vaccine will need to stop the infection dead in its tracks, not just reduce the amount of virus and leave the remainder to stay with the person forever.
- Where do things stand now? -
Efforts to develop a vaccine have been going on for decades but have so far all ended in failure.
Last year, a study called Uhambo that was taking place in South Africa and involved the only vaccine candidate ever shown to provide some protection against the virus frustratingly ended in failure.
J&J's vaccine candidate is currently being trialed in 2,600 women in sub-Saharan Africa in the Imbokodo trial, which is expected to report results in the coming months.
It's also being tested in around 3,800 men who have sex with men and transgender individuals across the US, South America and Europe in the Mosaico trial.
The J&J vaccine uses similar adenovirus technology to its Covid-19 vaccine, in other words a genetically modified cold virus delivers genetic cargo carrying instructions for the host to develop "mosaic immunogens" -- molecules capable of inducing an immune response to a wide variety of HIV strains.
This is followed up by directly injecting synthetic proteins in later doses.
Another promising approach is to try to generate "broadly neutralizing antibodies" (bnAbs) which bind to areas of the HIV virus that are common across its many variants.
The International AIDS Vaccine Initiative and Scripps Research recently announced results from an early stage trial showing their vaccine candidate stimulated the production of rare immune cells needed as a first step in the process of inducing bnAbs.
They are partnering with Moderna in the next stage of developing an mRNA vaccine.
Their strategy, explained Schief, is to use a sequence of shots to try to gradually educate antibody producing B-cells. They also hope to train up another kind of white cell, known as T-cells, to kill any cells that still get infected despite the antibodies.
Efficacy trials are still a long way off, but he's hopeful the mRNA technology, which turn the body's cells into vaccine factories and has proven its worth against Covid-19, can make the difference.
ETX Studio
Tue Jun 08 2021
HIV also has spike-shaped proteins on its surface, which are the target of HIV vaccine development. ETXStudiopic
Who is Prabowo Subianto, incoming president of Indonesia?
A wealthy ex-general with ties to Indonesia's popular outgoing president and its dictatorial past, looks set to be its next leader.
Iran's supreme leader says Hamas leader's death will not halt 'Axis of Resistance'
The "Axis of Resistance", built up with years of Iranian support, includes Hamas, the Lebanese Hezbollah group, the Houthi movement in Yemen, and various Shi'ite groups in Iraq and Syria.
Putin says Russia willing to seek compromises between Iran and Israel
Russia is ready to help seek compromises between arch-foes Israel and Iran, President Vladimir Putin said on Friday, saying these would be difficult but possible.
What proposals will Russia push at the BRICS summit?
The proposal is also to establish a BRICS reinsurance company to allow uninterrupted shipment of goods and key commodities between members.
Indonesia's free meals plan in the spotlight as Prabowo readies for office
Prabowo calls the programme one of the main drivers of economic growth, eventually set to add an estimated 2.5 million jobs.
Astro AWANI's revamped English news website, AWANI International, launches on Oct 21
Astro AWANI's revamped English platform delivers in-depth global news and expert analysis to keep you informed on key developments.
Israeli strikes kill 33 people in Jabalia refugee camp in Gaza, medics say
Residents of Jabalia said Israeli tanks had reached the heart of the camp after pushing through suburbs and residential districts.
Liam Payne's ex-partner calls for media restraint after 'painful' death
Cheryl Tweedy used her statement to urge the media to remember they had a seven-year-old son, Bear, who could read the reports.
Analysts: Indonesia's strong MoF leadership team to boost investor confidence
Sri Mulyani Indrawati as head of Indonesia's Ministry of Finance is expected to instil confidence among investors.
Biden offers both a carrot and a stick to Israel as his term nears an end
Israel has frequently resisted US advice and has caused political difficulties for the Biden administration.
Putin says BRICS will generate most of global economic growth
Russian President Vladimir Putin will host a summit of the group in the city of Kazan on Oct. 22-24.
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.